Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Merck
Colorcon
Harvard Business School
Baxter

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,115,634

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,115,634
Title:4-aminopiperidine and their use as a medicine
Abstract: A subject of the present application is new derivatives of 4-aminopiperidines of formula ##STR00001## in which R.sub.1, R.sub.2 and R.sub.3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.
Inventor(s): Thurieau; Christophe (Paris, FR), Gonzalez; Jerome (Annemasse, FR), Moinet; Christophe (Montreal, CA)
Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (FR)
Application Number:10/130,924
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 7,115,634

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acadia Pharms Inc NUPLAZID pimavanserin tartrate CAPSULE;ORAL 210793-001 Jun 28, 2018 RX Yes Yes   Request a Trial   Request a Trial Y Y   Request a Trial
Acadia Pharms Inc NUPLAZID pimavanserin tartrate TABLET;ORAL 207318-002 Jun 28, 2018 RX Yes Yes   Request a Trial   Request a Trial Y Y   Request a Trial
Acadia Pharms Inc NUPLAZID pimavanserin tartrate TABLET;ORAL 207318-001 Apr 29, 2016 DISCN Yes No   Request a Trial   Request a Trial Y Y   Request a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,115,634

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France99 15724Dec 14, 1999
PCT Information
PCT FiledDecember 13, 2000PCT Application Number:PCT/FR00/03497
PCT Publication Date:June 21, 2001PCT Publication Number: WO01/44191

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Baxter
AstraZeneca
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.